US Stock MarketDetailed Quotes

VTYX Ventyx Biosciences

Watchlist
  • 2.240
  • -0.040-1.75%
Close Dec 20 16:00 ET
  • 2.240
  • 0.0000.00%
Post 18:17 ET
158.39MMarket Cap-0.95P/E (TTM)

Ventyx Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-2.30%-35.46M
50.21%-24.54M
-54.02%-47.63M
-68.59%-166.52M
-9.29%-51.66M
-44.50%-34.66M
-233.17%-49.28M
-142.98%-30.92M
-155.55%-98.77M
-221.81%-47.26M
Net income from continuing operations
34.76%-35.25M
40.00%-31.95M
0.92%-38.57M
-77.97%-192.96M
-32.77%-46.75M
-77.36%-54.03M
-166.02%-53.25M
-71.26%-38.93M
-29.47%-108.43M
-98.19%-35.21M
Operating gains losses
--0
--2K
--98K
----
----
----
----
----
----
----
Depreciation and amortization
16.60%309K
127.34%316K
204.48%408K
100.21%941K
168.67%403K
108.66%265K
34.95%139K
48.89%134K
1,466.67%470K
837.50%150K
Other non cash items
--0
--0
---88K
----
----
----
----
----
----
----
Change In working capital
-125.41%-3.36M
363.22%4.07M
-512.46%-13.97M
212.58%5.81M
39.46%-9.26M
415.59%13.23M
-240.51%-1.55M
-47.67%3.39M
-228.41%-5.16M
-969.53%-15.3M
-Change in prepaid assets
-59.45%2.92M
94.01%-316K
-235.05%-5.08M
107.39%616K
25.40%-5.06M
270.23%7.19M
-117.71%-5.27M
-26.30%3.76M
-90.06%-8.34M
-818.40%-6.79M
-Change in payables and accrued expense
-199.67%-6.05M
20.67%4.62M
-3,092.34%-8.75M
49.76%5.25M
48.02%-4.37M
-11.83%6.07M
6.43%3.83M
-119.07%-274K
-58.28%3.51M
-436.63%-8.41M
-Change in other current liabilities
-521.62%-230K
-129.00%-229K
-52.58%-148K
81.90%-59K
276.77%175K
59.34%-37K
-38.89%-100K
-51.56%-97K
---326K
---99K
Cash from discontinued investing activities
Operating cash flow
-2.30%-35.46M
50.21%-24.54M
-54.02%-47.63M
-68.59%-166.52M
-9.29%-51.66M
-44.50%-34.66M
-233.17%-49.28M
-142.98%-30.92M
-155.55%-98.77M
-221.81%-47.26M
Investing cash flow
Cash flow from continuing investing activities
-24.80%29.25M
-316.89%-75.52M
321.04%41.77M
234.71%100.94M
132.75%46.13M
-39.39%38.89M
90.79%34.82M
-14.49%-18.9M
65.05%-74.93M
1.57%-140.84M
Net PPE purchase and sale
--0
69.23%-60K
-191.67%-175K
-86.91%-514K
-88.39%-211K
50.52%-48K
-596.43%-195K
-57.89%-60K
-4.96%-275K
-133.33%-112K
Net investment purchase and sale
-24.89%29.25M
-315.51%-75.46M
322.67%41.94M
235.90%101.45M
132.93%46.34M
-39.40%38.94M
91.56%35.01M
-14.39%-18.84M
65.44%-74.66M
1.62%-140.73M
Cash from discontinued investing activities
Investing cash flow
-24.80%29.25M
-316.89%-75.52M
321.04%41.77M
234.71%100.94M
132.75%46.13M
-39.39%38.89M
90.79%34.82M
-14.49%-18.9M
65.05%-74.93M
1.57%-140.84M
Financing cash flow
Cash flow from continuing financing activities
1,553.05%26.86M
-136.64%-906K
97.72%96.18M
-68.21%53.33M
105.65%585K
-99.09%1.63M
893.17%2.47M
56,465.12%48.65M
-48.15%167.77M
-106.49%-10.36M
Net common stock issuance
--0
-2,125.53%-1.05M
98.31%96.09M
-70.73%48.41M
--0
--0
---47K
--48.46M
4.15%165.4M
-107.01%-11.13M
Proceeds from stock option exercised by employees
-99.30%12K
-94.55%140K
-57.41%92K
107.29%4.92M
-44.14%434K
34.94%1.7M
931.33%2.57M
151.16%216K
3,552.31%2.37M
3,600.00%777K
Net other financing activities
----
----
----
----
----
---78K
---48K
---25K
----
----
Cash from discontinued financing activities
Financing cash flow
1,553.05%26.86M
-136.64%-906K
97.72%96.18M
-68.21%53.33M
105.65%585K
-99.09%1.63M
893.17%2.47M
56,465.12%48.65M
-48.15%167.77M
-106.49%-10.36M
Net cash flow
Beginning cash position
-18.98%41.9M
124.40%142.87M
-18.92%52.55M
-8.44%64.82M
-78.13%57.59M
14.06%51.72M
52.72%63.67M
-8.44%64.82M
28,912.70%70.79M
281.63%263.27M
Current changes in cash
252.84%20.65M
-742.07%-100.96M
7,820.00%90.32M
-106.63%-12.25M
97.51%-4.95M
-97.32%5.85M
-423.44%-11.99M
95.99%-1.17M
-108.41%-5.93M
-11,094.96%-198.46M
Effect of exchange rate changes
1,100.00%192K
-123.68%-9K
-125.00%-5K
71.43%-12K
-1,175.00%-86K
142.11%16K
170.37%38K
-52.38%20K
-481.82%-42K
--8K
End cash Position
8.95%62.74M
-18.98%41.9M
124.40%142.87M
-18.92%52.55M
-18.92%52.55M
-78.13%57.59M
14.06%51.72M
52.72%63.67M
-8.44%64.82M
-8.44%64.82M
Free cash flow
-2.16%-35.46M
50.28%-24.6M
-54.29%-47.8M
-68.64%-167.04M
-9.48%-51.87M
-44.12%-34.71M
-233.85%-49.48M
-142.72%-30.98M
-154.54%-99.05M
-221.52%-47.38M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -2.30%-35.46M50.21%-24.54M-54.02%-47.63M-68.59%-166.52M-9.29%-51.66M-44.50%-34.66M-233.17%-49.28M-142.98%-30.92M-155.55%-98.77M-221.81%-47.26M
Net income from continuing operations 34.76%-35.25M40.00%-31.95M0.92%-38.57M-77.97%-192.96M-32.77%-46.75M-77.36%-54.03M-166.02%-53.25M-71.26%-38.93M-29.47%-108.43M-98.19%-35.21M
Operating gains losses --0--2K--98K----------------------------
Depreciation and amortization 16.60%309K127.34%316K204.48%408K100.21%941K168.67%403K108.66%265K34.95%139K48.89%134K1,466.67%470K837.50%150K
Other non cash items --0--0---88K----------------------------
Change In working capital -125.41%-3.36M363.22%4.07M-512.46%-13.97M212.58%5.81M39.46%-9.26M415.59%13.23M-240.51%-1.55M-47.67%3.39M-228.41%-5.16M-969.53%-15.3M
-Change in prepaid assets -59.45%2.92M94.01%-316K-235.05%-5.08M107.39%616K25.40%-5.06M270.23%7.19M-117.71%-5.27M-26.30%3.76M-90.06%-8.34M-818.40%-6.79M
-Change in payables and accrued expense -199.67%-6.05M20.67%4.62M-3,092.34%-8.75M49.76%5.25M48.02%-4.37M-11.83%6.07M6.43%3.83M-119.07%-274K-58.28%3.51M-436.63%-8.41M
-Change in other current liabilities -521.62%-230K-129.00%-229K-52.58%-148K81.90%-59K276.77%175K59.34%-37K-38.89%-100K-51.56%-97K---326K---99K
Cash from discontinued investing activities
Operating cash flow -2.30%-35.46M50.21%-24.54M-54.02%-47.63M-68.59%-166.52M-9.29%-51.66M-44.50%-34.66M-233.17%-49.28M-142.98%-30.92M-155.55%-98.77M-221.81%-47.26M
Investing cash flow
Cash flow from continuing investing activities -24.80%29.25M-316.89%-75.52M321.04%41.77M234.71%100.94M132.75%46.13M-39.39%38.89M90.79%34.82M-14.49%-18.9M65.05%-74.93M1.57%-140.84M
Net PPE purchase and sale --069.23%-60K-191.67%-175K-86.91%-514K-88.39%-211K50.52%-48K-596.43%-195K-57.89%-60K-4.96%-275K-133.33%-112K
Net investment purchase and sale -24.89%29.25M-315.51%-75.46M322.67%41.94M235.90%101.45M132.93%46.34M-39.40%38.94M91.56%35.01M-14.39%-18.84M65.44%-74.66M1.62%-140.73M
Cash from discontinued investing activities
Investing cash flow -24.80%29.25M-316.89%-75.52M321.04%41.77M234.71%100.94M132.75%46.13M-39.39%38.89M90.79%34.82M-14.49%-18.9M65.05%-74.93M1.57%-140.84M
Financing cash flow
Cash flow from continuing financing activities 1,553.05%26.86M-136.64%-906K97.72%96.18M-68.21%53.33M105.65%585K-99.09%1.63M893.17%2.47M56,465.12%48.65M-48.15%167.77M-106.49%-10.36M
Net common stock issuance --0-2,125.53%-1.05M98.31%96.09M-70.73%48.41M--0--0---47K--48.46M4.15%165.4M-107.01%-11.13M
Proceeds from stock option exercised by employees -99.30%12K-94.55%140K-57.41%92K107.29%4.92M-44.14%434K34.94%1.7M931.33%2.57M151.16%216K3,552.31%2.37M3,600.00%777K
Net other financing activities -----------------------78K---48K---25K--------
Cash from discontinued financing activities
Financing cash flow 1,553.05%26.86M-136.64%-906K97.72%96.18M-68.21%53.33M105.65%585K-99.09%1.63M893.17%2.47M56,465.12%48.65M-48.15%167.77M-106.49%-10.36M
Net cash flow
Beginning cash position -18.98%41.9M124.40%142.87M-18.92%52.55M-8.44%64.82M-78.13%57.59M14.06%51.72M52.72%63.67M-8.44%64.82M28,912.70%70.79M281.63%263.27M
Current changes in cash 252.84%20.65M-742.07%-100.96M7,820.00%90.32M-106.63%-12.25M97.51%-4.95M-97.32%5.85M-423.44%-11.99M95.99%-1.17M-108.41%-5.93M-11,094.96%-198.46M
Effect of exchange rate changes 1,100.00%192K-123.68%-9K-125.00%-5K71.43%-12K-1,175.00%-86K142.11%16K170.37%38K-52.38%20K-481.82%-42K--8K
End cash Position 8.95%62.74M-18.98%41.9M124.40%142.87M-18.92%52.55M-18.92%52.55M-78.13%57.59M14.06%51.72M52.72%63.67M-8.44%64.82M-8.44%64.82M
Free cash flow -2.16%-35.46M50.28%-24.6M-54.29%-47.8M-68.64%-167.04M-9.48%-51.87M-44.12%-34.71M-233.85%-49.48M-142.72%-30.98M-154.54%-99.05M-221.52%-47.38M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List